Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature (70)
British Journal of Cancer (67)
Leukemia (6)
Nature Communications (6)
Pediatric Research (5)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (160)
Books & Arts (7)
News & Views (4)
News (3)
Reviews (3)
Amendments and Corrections (2)
Comments & Opinion (2)
Correspondence (2)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biophysics
Biotechnology
Cancer
Cell biology
Chemical biology
Computational biology and bioinformatics
Diseases
Drug discovery
Ecology
Genetics
Health care
Immunology
Materials science
Medical research
Molecular biology
Neuroscience
Solid Earth sciences
Stem cells
Structural biology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 101–150 of 183 results

Advanced filters: Author: G. Calvert Clear advanced filters

Immunoparasitology anew

F.E.G. Cox
Books & Arts03 Mar 1983
Nature

Volume: 302, P: 90-91
Fostering interactions

Michael G. B. Drew
Comments & Opinion03 Oct 1991
Nature

Volume: 353, P: 472-473
Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds

L Tentori
M Turriziani
G Graziani
Research12 Jun 1999
Leukemia

Volume: 13, P: 901-909
Geometry of Four Dimensions

J. G. S.
Books & Arts31 Jan 1931
Nature

Volume: 127, P: 155-156
Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease

G Egan
K A Cervone
S L Gardner
Research04 Jan 2016
Bone Marrow Transplantation

Volume: 51, P: 542-545
Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours

C Kosmas
G Vorgias
N Mylonakis
ResearchOpen Access16 Aug 2011
British Journal of Cancer

Volume: 105, P: 897-902
The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

P Mistry
LR Kelland
KR Harrap
Research01 Aug 1991
British Journal of Cancer

Volume: 64, P: 215-220
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours

I A McNeish
E J Kanfer
M J Seckl
ResearchOpen Access09 Mar 2004
British Journal of Cancer

Volume: 90, P: 1169-1175
Author Correction: CD98hc is a target for brain delivery of biotherapeutics

Kylie S. Chew
Robert C. Wells
Mihalis S. Kariolis
Amendments and CorrectionsOpen Access07 Sept 2023
Nature Communications

Volume: 14, P: 1
242 INDUCTION OF CRYPTS FORMATION IN CULTURED FETAL MOUSE DUODENUM

G Bordeleau
F Bouthillier
R Calvert
Research01 Apr 1985
Pediatric Research

Volume: 19, P: 151
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer

J-P Sculier
J-J Lafitte
J Klastersky
ResearchOpen Access10 Oct 2000
British Journal of Cancer

Volume: 83, P: 1128-1135
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group

S Pignata
G Scambia
F Perrone
ResearchOpen Access08 May 2007
British Journal of Cancer

Volume: 96, P: 1639-1643
Chemotherapy and the war on cancer

Bruce A. Chabner
Thomas G. Roberts Jr
Reviews01 Jan 2005
Nature Reviews Cancer

Volume: 5, P: 65-72
Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia

In a human subject with chronic paraplegia, a combination of epidural electrical stimulation and long-term rehabilitative training have culminated in the first report of unassisted, voluntary independent stepping in a paralyzed individual.

Megan L. Gill
Peter J. Grahn
Kristin D. Zhao
Research24 Sept 2018
Nature Medicine

Volume: 24, P: 1677-1682
Estimation of glomerular filtration rate in paediatric cancer patients using ⁵¹CR-EDTA population pharmacokinetics

M Cole
L Price
G J Veal
ResearchOpen Access06 Jan 2004
British Journal of Cancer

Volume: 90, P: 60-64
Geological Work in the United States

G. A. J. C.
News02 Nov 1911
Nature

Volume: 88, P: 21-23
Observation of the rare B_s⁰ →µ⁺µ⁻ decay from the combined analysis of CMS and LHCb data

Combined analysis of proton-proton collision data from the Large Hadron Collider at CERN by the CMS and LHCb collaborations leads to the observation of the extremely rare decay of the strange B meson into muons; the result is compatible with the standard model of particle physics, and does not show any signs of new physics, such as supersymmetry.

V. Khachatryan
A.M. Sirunyan
E. Pesen
ResearchOpen Access13 May 2015
Nature

Volume: 522, P: 68-72
Geological Work in the United States

G. A. J. C.
News23 Jul 1908
Nature

Volume: 78, P: 282-284
241 HUMAN FETAL UMBILICAL BLOOD FLOW ESTIMATION BY APPLICATION OF THE BOHR PRINCIPLE

Duane R Bonds
Lon O Crosby
M Delivoria-Papadopoulos
Research01 Apr 1985
Pediatric Research

Volume: 19, P: 151
244 HYPOXIA, LUNG GROWTH AMD THE SURFACTANT SYSTEM DURING ALVEOLARIZATION

D Buohter
K Franke
G Brumley
Research01 Apr 1985
Pediatric Research

Volume: 19, P: 151
New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex')

G Blackledge
Research01 Jan 1998
British Journal of Cancer

Volume: 77, P: 29-37
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1

Heather Mefford, Ingrid Scheffer and colleagues report targeted resequencing of 47 genes in 500 individuals with epileptic encephalopathies. They identify pathogenic mutations in 11% of their cohort and show that de novo mutations in CHD2 and SYNGAP1 cause epileptic encephalopathy.

Gemma L Carvill
Sinéad B Heavin
Heather C Mefford
Research26 May 2013
Nature Genetics

Volume: 45, P: 825-830
ABO Blood Groups, Rhesus Factor and Intestinal Metaplasia of the Stomach

G Glober
A S Peña
S C Truelove
Research01 Oct 1972
British Journal of Cancer

Volume: 26, P: 420-422
Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer

PJ Woll
R Basser
N Thatcher
Research01 Jul 1997
British Journal of Cancer

Volume: 76, P: 264-265
Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes

SY Loh
P Mistry
KR Harrap
Research01 Dec 1992
British Journal of Cancer

Volume: 66, P: 1109-1115
Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes

CA Hills
LR Kelland
KR Harrap
Research01 Apr 1989
British Journal of Cancer

Volume: 59, P: 527-534
Disruptions to the hearing health sector

Technological innovation and changes to regulation are disrupting the hearing health sector, with implications for data privacy, product safety and accessibility, and provide challenges and opportunities for equitable hearing health.

Isabelle Boisvert
Adam G. Dunn
Melanie Calvert
Comments & Opinion05 Jan 2023
Nature Medicine

Volume: 29, P: 19-21
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

W K A Yung
R E Albright
V A Levin
ResearchOpen Access08 Aug 2000
British Journal of Cancer

Volume: 83, P: 588-593
A unified definition of clinical anthracycline resistance breast cancer

X Pivot
L Asmar
G Hortobagyi
ResearchOpen Access07 Jan 2000
British Journal of Cancer

Volume: 82, P: 529-534
Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site

A Piga
R Nortilli
R Cellerino
ResearchOpen Access13 Apr 2004
British Journal of Cancer

Volume: 90, P: 1898-1904
Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer

ME Gore
G Rustin
JM Thompson
Research01 Mar 1997
British Journal of Cancer

Volume: 75, P: 710-714
Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer

G V Kornek
M Raderer
W Scheithauer
ResearchOpen Access11 Jun 2002
British Journal of Cancer

Volume: 86, P: 1858-1863
Responses of Gastrointestinal Peptides and Motor Activity to Milk and Water Feedings in Preterm and Term Infants

Carol Lynn Berseth
Cynthia K Nordyke
Vay Liang W Go
Research01 Jun 1992
Pediatric Research

Volume: 31, P: 587-592
SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer

P A Vasey
R Atkinson
G J S Rustin
ResearchOpen Access11 Jan 2006
British Journal of Cancer

Volume: 94, P: 62-68
Influence of ATM function on telomere metabolism

Lubomir B Smilenov
Susan E Morgan
Tej K Pandita
Research27 Nov 1997
Oncogene

Volume: 15, P: 2659-2665
Low central nervous system penetration of N²,N⁴,N⁶,-trihydroxymethyl-N²,N⁴,N⁶,-trimethylmelamine (Trimelamol): A cytotoxic s-triazine with reduced neurotoxicity

I R Judson
C J Rutty
M A Graham
Research01 May 1986
British Journal of Cancer

Volume: 53, P: 601-606
Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro

MJ McKeage
G Abel
KR Harrap
Research01 Jan 1994
British Journal of Cancer

Volume: 69, P: 1-7
Pharmacokinetics of ethylenediaminemalonatoplatinum(II) (JM-40) during phase I trial

F Elferink
WJF van der Vijgh
JG McVie
Research01 Dec 1987
British Journal of Cancer

Volume: 56, P: 479-483
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer

A R Clamp
J Mäenpää
G C Jayson
ResearchOpen Access13 Dec 2005
British Journal of Cancer

Volume: 94, P: 55-61
Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

C K Lee
H Gurney
M Friedlander
ResearchOpen Access12 Jul 2011
British Journal of Cancer

Volume: 105, P: 360-365
The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL

P Nygren
K Csoka
R Larsson
Research01 Mar 1995
British Journal of Cancer

Volume: 71, P: 478-481
Carboplatin plus cytarabine in the treatment of high-risk acute myeloblastic leukemia

L Larrea
JA Martínez
MA Sanz
Research05 Feb 1999
Leukemia

Volume: 13, P: 161-165
Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer

M Ponz de Leon
P Benatti
L Roncucci
ResearchOpen Access17 Feb 2004
British Journal of Cancer

Volume: 90, P: 882-887
An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre

P S Sengupta
G C Jayson
J A Radford
ResearchOpen Access09 Apr 1999
British Journal of Cancer

Volume: 80, P: 444-447
Protein activation mapping of human sun-protected epidermis after an acute dose of erythemic solar simulated light

Janine G. Einspahr
Clara Curiel-Lewandrowski
Emanuel F. Petricoin III
ResearchOpen Access21 Sept 2017
npj Precision Oncology

Volume: 1, P: 1-10
A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer

A E Guppy
A E Nelstrop
G J S Rustin
ResearchOpen Access17 Feb 2004
British Journal of Cancer

Volume: 90, P: 810-814
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours

S Dallorso
G Dini
M L Garrè
Research06 Apr 2005
Bone Marrow Transplantation

Volume: 35, P: S31-S34
A national survey of restorative consultants' treatment provision for head and neck oncology patients

G. Calvert
S. C. Barclay
A. Alani
Research21 Nov 2014
British Dental Journal

Volume: 217, P: E21
Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the ‘Head Start’ trials, 1991–2009

C Altshuler
K Haley
J L Finlay
Research07 Mar 2016
Bone Marrow Transplantation

Volume: 51, P: 945-948
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk

Richard Houlston and colleagues report a genome-wide association study for colorectal cancer. They report three loci newly associated with colorectal cancer, bringing the total number of common susceptibility loci to 20.

Malcolm G Dunlop
Sara E Dobbins
Richard S Houlston
Research27 May 2012
Nature Genetics

Volume: 44, P: 770-776

Previous page
page 1
page 2
page 3
page 4
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited